152 related articles for article (PubMed ID: 2905544)
1. Evaluation of the developmental toxicity of nicotine and cotinine with frog embryo teratogenesis assay: Xenopus.
Dawson DA; Fort DJ; Smith GJ; Newell DL; Bantle JA
Teratog Carcinog Mutagen; 1988; 8(6):329-38. PubMed ID: 2905544
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Bantle JA
Teratog Carcinog Mutagen; 1990; 10(6):463-76. PubMed ID: 1982910
[TBL] [Abstract][Full Text] [Related]
3. Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens.
Bantle JA; Fort DJ; Rayburn JR; DeYoung DJ; Bush SJ
Drug Chem Toxicol; 1990; 13(4):267-82. PubMed ID: 1703942
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
Fort DJ; James BL; Bantle JA
J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the toxicity and teratogenity of six commercial textile dyes using the frog embryo teratogenesis assay-Xenopus.
Birhanli A; Ozmen M
Drug Chem Toxicol; 2005; 28(1):51-65. PubMed ID: 15720035
[TBL] [Abstract][Full Text] [Related]
6. Developmental toxicity testing with FETAX: evaluation of five compounds.
Dawson DA; Fort DJ; Newell DL; Bantle JA
Drug Chem Toxicol; 1989 Mar; 12(1):67-75. PubMed ID: 2714209
[TBL] [Abstract][Full Text] [Related]
7. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
Fort DJ; Bantle JA
Fundam Appl Toxicol; 1990 May; 14(4):720-33. PubMed ID: 2361573
[TBL] [Abstract][Full Text] [Related]
8. Teratogenic assessment of four solvents using the Frog Embryo Teratogenesis Assay--Xenopus (FETAX).
Dresser TH; Rivera ER; Hoffmann FJ; Finch RA
J Appl Toxicol; 1992 Feb; 12(1):49-56. PubMed ID: 1564253
[TBL] [Abstract][Full Text] [Related]
9. Assessing the efficacy of an Aroclor 1254-induced exogenous metabolic activation system for FETAX.
Fort DJ; Rayburn JR; DeYoung DJ; Bantle JA
Drug Chem Toxicol; 1991; 14(1-2):143-60. PubMed ID: 1889373
[TBL] [Abstract][Full Text] [Related]
10. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Dawson DA; Bantle JA
Teratog Carcinog Mutagen; 1988; 8(5):251-63. PubMed ID: 2905834
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus.
Fort DJ; Stover EL; Rayburn JR; Hull M; Bantle JA
Teratog Carcinog Mutagen; 1993; 13(1):35-45. PubMed ID: 8100651
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Teratogenicity of Ritodrine and Nifedipine using a Frog Embryo Teratogenesis assay (FETAX).
Boğa Pekmezekmek A; Binokay US; Seçilmiş MA; Kumcu E; Şimşek E; Akillioğlu K; Sertdemir Y; Özaykan B
Drug Chem Toxicol; 2015; 38(3):254-65. PubMed ID: 25156158
[TBL] [Abstract][Full Text] [Related]
13. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
Fort DJ; Rogers RL; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429
[TBL] [Abstract][Full Text] [Related]
14. FETAX Assay for Evaluation of Developmental Toxicity.
Mouche I; Malésic L; Gillardeaux O
Methods Mol Biol; 2017; 1641():311-324. PubMed ID: 28748472
[TBL] [Abstract][Full Text] [Related]
15. Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system.
Bantle JA; Finch RA; Fort DJ; Stover EL; Hull M; Kumsher-King M; Gaudet-Hull AM
J Appl Toxicol; 1999; 19(6):447-72. PubMed ID: 10547627
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification.
Fort DJ; Stover EL; Bantle JA; Finch RA
Teratog Carcinog Mutagen; 2000; 20(1):35-47. PubMed ID: 10607376
[TBL] [Abstract][Full Text] [Related]
17. Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX).
Fort DJ; Stover EL; Bantle JA; Rayburn JR; Hull MA; Finch RA; Burton DT; Turley SD; Dawson DA; Linder G; Buchwalter D; Dumont JN; Kumsher-King M; Gaudet-Hull AM
Drug Chem Toxicol; 1998 Feb; 21(1):1-14. PubMed ID: 9530526
[TBL] [Abstract][Full Text] [Related]
18. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX).
Fort DJ; Stover EL; Farmer DR; Lemen JK
Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752
[TBL] [Abstract][Full Text] [Related]
19. Potential protective effect of L-cysteine against the toxicity of acrylamide and furan in exposed Xenopus laevis embryos: an interaction study.
Williams JR; Rayburn JR; Cline GR; Sauterer R; Friedman M
J Agric Food Chem; 2014 Aug; 62(31):7927-38. PubMed ID: 25055136
[TBL] [Abstract][Full Text] [Related]
20. Mortality and malformation effects of acute vanadium (V) exposure on the African clawed frog (Xenopus laevis) embryos.
Dahms-Verster S; Nel A; van Vuren JHJ; Greenfield R
Environ Sci Pollut Res Int; 2023 Apr; 30(19):55730-55741. PubMed ID: 36899118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
